Abdominal Mass in a Phenotypic Female with 46,XY Differences in Sex Development.
暂无分享,去创建一个
[1] Mostafa El-Feky. Androgen insensitivity syndrome. , 2019, Bailliere's clinical endocrinology and metabolism.
[2] H. Stoop,et al. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling , 2017, Human reproduction.
[3] L. Wünsch,et al. Gonadectomy in Complete Androgen Insensitivity Syndrome: Why and When? , 2017, Sexual Development.
[4] L. Looijenga,et al. Update on the Pathophysiology and Risk Factors for the Development of Malignant Testicular Germ Cell Tumors in Complete Androgen Insensitivity Syndrome , 2017, Sexual Development.
[5] D. Poppas,et al. Surgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how? , 2016, Journal of pediatric urology.
[6] G. Conway,et al. Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence , 2012, Clinical endocrinology.
[7] L. Looijenga,et al. Gonadal Development and Tumor Formation at the Crossroads of Male and Female Sex Determination , 2011, Sexual Development.
[8] L. Looijenga,et al. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. , 2006, Endocrine reviews.